, GHK-Cu
In the STEP UP clinical trial, the 7.2-mg dose demonstrated a mean weight loss of 20.7% at 72 weeks, compared with a reduction of 17.5% with the previously approved semaglutide (Wegovy) injection (2.4 mg) and 2.4% with placebo
rda i literatura PubMed Regenerative and Protective Actions of the GHK-Cu Peptide (2018) PubMed The potential of GHK as an anti-aging peptide (2022) MDPI Skin Regenerative and Anti-Cancer Actions of Copper Peptides Wicej artykuw naukowych i praktycznych znajdziesz w naszej bazie wiedzy BIOCATALYST
Reduced Glutathione Duration: Similar to standard oral supplements, approximately 23 hours
AbbVie, which paid $350 million to license a long-acting amylin analog from the firm Gubra, also recently announced Phase 1 data
This article explores how BPC-157 improves gut health, the science behind its healing potential, and how it fits into a broader, responsible approach to wellness